Market Overview

Mediware Acquires Transtem to Expand With Cellular Therapy Software; Terms Not Disclosed

Mediware® Information Systems, Inc. (Nasdaq: MEDW) today announced that it has acquired substantially all the assets of St. Louis-based Transtem, LLC, a provider of software that manages the collection and transplantation of adult stem cells in cellular-based therapies and medical research.

The acquisition continues the expansion of Mediware's blood management expertise and extends the company with software and domain expertise in a rapidly growing field that includes cancer treatment and regenerative medicine. Details related to the acquisition were not released.

Posted-In: News M&A

 

Related Articles (MEDW)

Around the Web, We're Loving...

Get Benzinga's Newsletters